Potential Drug Targets Against Hepatitis B Virus Based on Both Virus and Host Factors

Bing-Yi Zhang1, Dan-Ping Chai1, Yi-Hang Wu1

  • 1Department of Pharmacy, Zhejiang Provincial Key Laboratory of Biometrology and Inspection & Quarantine, College of Life Sciences, China Jiliang University, Hangzhou 310018, China.

Current Drug Targets
|August 1, 2019
PubMed

Insights

Discovering new hepatitis B virus (HBV) drug targets is crucial due to existing treatment limitations and drug resistance. This review summarizes viral, host, and immune targets for developing innovative HBV therapies.

Area of Science:

  • Hepatology
  • Virology
  • Drug Discovery

Background:

  • Hepatitis B virus (HBV) infection remains a significant global health burden despite available vaccines.
  • Current treatments like nucleoside analogues and interferon-alpha have limitations, including drug resistance due to HBV genome variability.
  • There is an urgent need for novel therapeutic strategies and drugs to effectively cure chronic hepatitis B.

Purpose of the Study:

  • To provide theoretical support for the development of innovative anti-HBV drugs.
  • To summarize current antiviral targets against hepatitis B virus infection.
  • To guide the design of new therapeutic agents by reviewing potential targets.

Main Methods:

  • Analysis of advances in potential drug targets for anti-HBV infection.
  • Focus on targeting the virus genome, host cellular functions, and virus-host protein interactions.
  • Emphasis on immune targets against chronic hepatitis B.

Main Results:

  • HBV, an obligate intracellular parasite, relies on host cell machinery for replication.
  • Targeting both viral and host factors presents a promising therapeutic approach.
  • A comprehensive summary of antiviral strategies targeting viral, host, and immune factors is presented.

Conclusions:

  • The review offers a summary of antiviral therapeutic strategies for HBV infection.
  • It highlights the importance of targeting virus, host, and immune factors for future drug design.
  • This work supports the development of innovative drugs against HBV.
Abstract

Related Concept Videos

What are Viruses?00:50

What are Viruses?

Overview
127.8K
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
539
Introduction to Virus01:28

Introduction to Virus

Viruses are unique biological entities that blur the boundary between living and non-living systems. Although they lack cellular structure and metabolic processes, they can exhibit characteristics of life when infecting a host. Their defining feature is a nucleic acid core, composed of either DNA or RNA, encapsulated within a protein coat called a capsid. This simple structure allows them to invade host cells and use their machinery for replication efficiently.Viral Structure and...
1.3K
Viruses of Archaea01:29

Viruses of Archaea

Archaeal viruses play a crucial role in the ecosystems of extremophilic archaea, particularly those belonging to the phyla Euryarchaeota and Crenarchaeota. By shaping host evolution and facilitating gene transfer, these viruses influence microbial communities and contribute to genetic diversity in extreme environments. The archaea they infect thrive in acidic hot springs and hydrothermal vents characterized by high temperatures and low pH. Archaeal viruses exhibit remarkable structural...
473
Factors Affecting Protein-Drug Binding: Drug-Related Factors01:18

Factors Affecting Protein-Drug Binding: Drug-Related Factors

Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
456
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
853